RVTY

Revvity
D

RVTY

154.470
USD
-2.56
(-1.63%)
Market Closed
Last updated: · Delayed 15 min
Volume
57,901
EPS
5
Div Yield
0.18
P/E
69
Market Cap
17,244,838,794
Related Instruments

Title: Revvity

Sector: Healthcare
Industry: Diagnostics & Research
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.

Common questions about Revvity stock